Offer - Urjas Oil for just ₹ 1 X
Movexx Sp, a prescription drug, is manufactured in various forms such as Tablet. Movexx Sp also has some secondary and off-label uses. These are listed below.
The right dosage of Movexx Sp depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
The most common side effects of Movexx Sp are Nausea or vomiting, Diarrhoea, Dizziness. These side effects of Movexx Sp are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Movexx Sp is Severe for pregnant women and Severe for women who are breastfeeding. It is important to know if Movexx Sp has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Movexx Sp related warnings section.
Movexx Sp is contraindicated in people with pre-existing medical conditions like Kidney Disease, Asthma, Heart Attack as it can result in adverse effects.
Drug reaction of Movexx Sp with other medicines has been reported. Refer to the list below for further details.
You should also be aware that Movexx Sp is not safe while driving, and is not addiction.
Movexx Sp is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Movexx Sp safe for pregnant women?
Movexx SP shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Movexx Sp safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Movexx SP. It should only be taken after medical advice.
What is the effect of Movexx Sp on the Kidneys?
Movexx SP may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Movexx Sp on the Liver?
Movexx SP can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Movexx Sp on the Heart?
Movexx SP can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Movexx Sp should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Movexx Sp unless your doctor advises you to do so -
Is this Movexx Sp habit forming or addictive?
No, you will not get addicted to Movexx Sp.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Movexx Sp. So it is best to avoid driving.
Is it safe?
Movexx Sp should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Movexx Sp for mental disorders.
Interaction between Food and Movexx Sp
Due to a lack of research, nothing can be said about the consequences of taking Movexx Sp together with food.
Interaction between Alcohol and Movexx Sp
No research has been done on this till date. Therefore, it is not known what the effect of taking Movexx Sp with alcohol will be.
Yes, Movexx SP is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as stomach pain, nausea, diarrhea, headache, difficulty in breathing, and constipation.
Movexx SP is a pain relieving medicine. One should take as long as he/she has been recommended to take. However, sometimes even after symptomatic relief your doctor may ask you to continue with medication to reduce inflammations in the body.
Yes, Movexx SP can be taken safely with a less sedative antihistaminic drug like cetirizine and loratadine etc. No harmful effects are reported. However, another group of antihistamine drug which causes drowsiness and sleepiness like chlorpheniramine, diphenhydramine etc. should not be taken together unless and until recommended by your doctor.
Yes, [medicine] can cause stomach upset. It is a common side effect of this drug. Please inform your doctor if you are experiencing stomach upset after taking this medicine.
Movexx SP is a brand name for aceclofenac. It is a prescription drug that belongs to the class of medications called NSAIDs (Nonsteroidal anti-inflammatory drug). It is mainly used to relieve pain in a patient's suffering from rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. Additionally, it also reduces fever.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)
Package Leaflet Information For The User [Internet]: Aceclofenac 100 mg film-coated Tablets. Accord Healthcare Limited
Package leaflet Information for the patient [Internet]: Paracetamol Tablets 500mg. actavis
Shivani Bhagat*, Monika Agarwal, Vandana Roy [Internet]: Serratiopeptidase: A systematic review of the existing evidence. International Journal of Surgery 11 (2013) 209e217